306 related articles for article (PubMed ID: 19601814)
1. Treatment of multiple sclerosis.
Anlar O
CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):167-74. PubMed ID: 19601814
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future.
Gholamzad M; Ebtekar M; Ardestani MS; Azimi M; Mahmodi Z; Mousavi MJ; Aslani S
Inflamm Res; 2019 Jan; 68(1):25-38. PubMed ID: 30178100
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Wingerchuk DM; Carter JL
Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
[TBL] [Abstract][Full Text] [Related]
5. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
6. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
Bates D
Neurology; 2011 Jan; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
[TBL] [Abstract][Full Text] [Related]
7. Teriflunomide for multiple sclerosis.
He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in multiple sclerosis, Part 2.
Becker CC; Gidal BE; Fleming JO
Am J Health Syst Pharm; 1995 Oct; 52(19):2105-20; quiz 2132-4. PubMed ID: 8535945
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in multiple sclerosis, Part 1.
Becker CC; Gidal BE; Fleming JO
Am J Health Syst Pharm; 1995 Sep; 52(18):1985-2000. PubMed ID: 8528866
[TBL] [Abstract][Full Text] [Related]
10. [Immunomodulatory therapy in multiple sclerosis].
Csépány T; Bereczki D
Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
[TBL] [Abstract][Full Text] [Related]
11. Moving Towards a Cure for MS: Increased Immunosuppression and Striving for No Evidence of Disease Activity (NEDA).
Wong B; Cahill J; Rizvi S
R I Med J (2013); 2018 Mar; 101(2):26-29. PubMed ID: 29490321
[TBL] [Abstract][Full Text] [Related]
12. Predicting and preventing the future: actively managing multiple sclerosis.
Hutchinson M
Pract Neurol; 2009 Jun; 9(3):133-43, discussion 144. PubMed ID: 19448055
[TBL] [Abstract][Full Text] [Related]
13. Current and future therapies targeting the immune system in multiple sclerosis.
Loleit V; Biberacher V; Hemmer B
Curr Pharm Biotechnol; 2014; 15(3):276-96. PubMed ID: 24938888
[TBL] [Abstract][Full Text] [Related]
14. A patient with established primary progressive multiple sclerosis transitions to 'secondary' relapsing-remitting disease course following a fulminant demyelinating episode.
Tutuncu M; Demirci NO; Özer F; Saip S; Kantarci OH; Siva A
Mult Scler; 2011 Oct; 17(10):1262-4. PubMed ID: 21135019
[TBL] [Abstract][Full Text] [Related]
15. Laquinimod for multiple sclerosis.
He D; Han K; Gao X; Dong S; Chu L; Feng Z; Wu S
Cochrane Database Syst Rev; 2013 Aug; (8):CD010475. PubMed ID: 23922214
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.
Nandoskar A; Raffel J; Scalfari AS; Friede T; Nicholas RS
Drugs; 2017 May; 77(8):885-910. PubMed ID: 28429241
[TBL] [Abstract][Full Text] [Related]
17. Secondary progressive multiple sclerosis: current knowledge and future challenges.
Rovaris M; Confavreux C; Furlan R; Kappos L; Comi G; Filippi M
Lancet Neurol; 2006 Apr; 5(4):343-54. PubMed ID: 16545751
[TBL] [Abstract][Full Text] [Related]
18. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
Sorensen PS; Sellebjerg F; Hartung HP; Montalban X; Comi G; Tintoré M
Brain; 2020 Sep; 143(9):2637-2652. PubMed ID: 32710096
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Treatment of Multiple Sclerosis: A Review.
McGinley MP; Goldschmidt CH; Rae-Grant AD
JAMA; 2021 Feb; 325(8):765-779. PubMed ID: 33620411
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis: a review of existing therapy and future prospects.
Khan OA
J Pak Med Assoc; 1996 Jan; 46(1):20-4. PubMed ID: 8830165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
